HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1244300Generated: November 1, 2026
Chloromethyl Methyl Ether → HCID 11305377, compound
https://huagongshe.com/reaction/1244300
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Chloromethyl Methyl Ether | HCID 7864 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 178491999 | HCID 178491999 | — |
| Catalyst | Tetrabutylammonium Iodide | HCID 67553 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 11305377 | HCID 11305377 | — |
Reaction Steps
Furthermore, 5-chloro-2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-3H-imidazo[4,5-b]pyridine (for R1=morpholinyl, Ic2) was dissolved in dry DMF and treated with NaH at 0° C. After stirring at ambient temperature for 1 h MOMCl and tetrabutyl ammonium iodide were added and the reaction mixture was stirred for about 16 h. The suspension was worked up to obtain the corresponding 5-chloro-3-methoxymethyl-2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-3H-imidazo[4,5-b]pyridine (Ic4), which was dissolved in morpholine (for R5=morpholin) in an autoclave and heated to about 150° C. for 16 h. The residue was triturated in water whereupon the precipitate was worked up to obtain the corresponding 3-methoxymethyl-2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-5-morpholin-4-yl-3H-imidazo[4,5-b]pyridine (Ic5). The corresponding 2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-5-morpholin-4-yl-3H-imidazo[4,5-b]pyridine (Ic1) was obtained by treating with HCl for about 1.5 h.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07122545B2 |
|---|
| Source dataset | uspto-grants-2006_10 |
|---|
| ORD ID | ord-a4f5b3de36f64ad197a11dc9bae86e8e |
|---|
| Source note | uspto-grants-2006_10 |
|---|